Bristol Myers Squibb is a global biopharmaceutical company founded in 1887 with approximately 32,500 employees operating across more than 100 countries. The company develops and delivers medicines with a focus on oncology, hematology, immunology, cardiology, fibrosis, and cell therapy.
The organisation combines the scale of a multinational pharmaceutical enterprise with the research intensity characteristic of biotech firms. Its therapeutic areas reflect a strategic emphasis on conditions requiring innovation in immunotherapy and cellular treatments, alongside core areas in cancer and blood disorders.
Bristol Myers Squibb operates with a patient-centric mission and explicit commitment to health equity, extending its work to vulnerable populations globally. The company's 135-year operational history provides established manufacturing, regulatory, and distribution infrastructure underpinning its development programmes across its portfolio of therapeutic domains.
